Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial

MLA

Lila, Bouadma, et al. “Use of Procalcitonin to Reduce Patients’ Exposure to Antibiotics in Intensive Care Units (PRORATA Trial): A Multicentre Randomised Controlled Trial.” The Lancet, vol. 375, Feb. 2010, pp. 463–74. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....517730f38fe886ab2c56885c1bdfc41b&authtype=sso&custid=ns315887.

APA

Lila, B., Charles-Edouard, L., Florence, T., Christophe, C., Antonio, A., Carole, S., Frédérique, S., Sigismond, L., Benoît, V., Monique, D., Maguy, B., Blandine, P., Bernard, R., Christian, B.-B., Jean, C., Michel, W., & Charles-Marie, B. (2010). Use of procalcitonin to reduce patients’ exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. The Lancet, 375, 463–474.

Chicago

Lila, Bouadma, Luyt Charles-Edouard, Tubach Florence, Cracco Christophe, Alvarez Antonio, Schwebel Carole, Schortgen Frédérique, et al. 2010. “Use of Procalcitonin to Reduce Patients’ Exposure to Antibiotics in Intensive Care Units (PRORATA Trial): A Multicentre Randomised Controlled Trial.” The Lancet 375 (February): 463–74. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....517730f38fe886ab2c56885c1bdfc41b&authtype=sso&custid=ns315887.